Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein
- 16 January 2002
- journal article
- Published by Elsevier BV in Veterinary Microbiology
- Vol. 85 (4), 295-303
- https://doi.org/10.1016/s0378-1135(01)00523-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administrationJournal of General Virology, 2001
- Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodiesVaccine, 2000
- Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen deliveryJournal of Controlled Release, 2000
- DNA-based non-invasive vaccination onto the skinVaccine, 1999
- FIRST NORTH AMERICAN FIELD RELEASE OF A VACCINIA-RABIES GLYCOPROTEIN RECOMBINANT VIRUSJournal of Wildlife Diseases, 1998
- Vaccination onto bare skinNature, 1997
- Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adultsVaccine, 1996
- Large-scale eradication of rabies using recombinant vaccinia-rabies vaccineNature, 1991
- Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine.Proceedings of the National Academy of Sciences of the United States of America, 1991
- History of Sabin attenuated poliovirus oral live vaccine strainsJournal of Biological Standardization, 1973